NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

細胞療法生物製造:全球市場

Cell Therapy Biomanufacturing: Global Markets

出版商 BCC Research 商品編碼 988626
出版日期 內容資訊 英文 112 Pages
訂單完成後即時交付
價格
細胞療法生物製造:全球市場 Cell Therapy Biomanufacturing: Global Markets
出版日期: 2021年02月11日內容資訊: 英文 112 Pages
簡介

全球細胞療法生物製造市場預計將從2020年的65億美元增長到2025年的102億美元,從2020年到2025年的複合年增長率為9.4%。

生物生產中的細胞療法將從2020年的36億美元增長到2025年的54億美元,預計從2020年到2025年的複合年增長率為8.4%。

細胞療法生物製造中的細胞來源將從2020年的29億美元增長到2025年的48億美元,預計從2020年到2025年的複合年增長率為10.6%。

該報告研究和分析了全球細胞療法生物製造市場,並提供了有關主要市場分析,市場推動者/抑制因素,競爭發展,市場趨勢等的系統信息。

目錄

第1章簡介

第2章摘要和重點

第3章市場/技術背景

  • 細胞療法生物製造的介紹
  • 什麼是細胞療法?
  • 幹細胞移植
  • 主頁
  • 同種異體
  • 相似
  • 幹細胞生物製造與分類
  • 分化能力基礎
  • 來源庫
  • 基於細胞的治療技術的分類
  • 體細胞技術
  • 3D技術
  • 細胞永生化技術
  • 基因組編輯技術
  • 細胞可塑性技術
  • 使用病毒載體技術對細胞進行離體基因重組
  • 使用病毒載體技術的細胞體內基因重組
  • 幹細胞應用
  • 細胞療法的機制
  • 如何提供基於細胞的治療
  • 細胞療法模型的製造
  • 寄件製造商的作用
  • 正在進行的臨床試驗
  • 專注於乾細胞治療的臨床試驗網絡

第4章市場趨勢和挑戰

  • 挑戰
  • 促進因素
  • 抑製器
  • 機會

第5章市場細分:按產品類型

  • 治療類型
  • 細胞來源
  • 對嵌合抗原受體(CAR)T細胞療法的需求迅速增加

第6章市場細分:按應用

  • 心血管疾病
  • 模仿細顆粒細胞
  • 骨修復
  • 神經系統疾病
  • 脊髓損傷
  • 中風
  • 帕金森氏病
  • 肌萎縮性側索硬化
  • 多發性硬化症
  • 腦癱
  • 阿爾茨海默氏病
  • 視力恢復
  • 脊柱修復
  • 巴頓病
  • 骨骼肌修復
  • 基本的治癒機制
  • 細胞療法的機制
  • 癌症
  • 其他疾病

第7章市場細分:按地區

  • 市場概況
  • 北美
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 歐洲心血管疾病
  • 心血管疾病(CVD)的因素
  • 德國
  • 英國
  • 法國
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 其他亞太地區
  • 世界其他地區
  • 南美洲
  • 中東/非洲

第8章監管結構

  • FDA批准
  • 調節CBER的細胞療法
  • 聯邦法規代碼
  • 細胞收集
  • 法規代碼
  • 規範干細胞療法使用的法律
  • 歐盟確定監管地位
  • 印度監管情景

第9章公司簡介

  • BONE THERAPEUTICS SA
  • BRISTOL-MYERS SQUIBB CO.
  • CALADRIUS BIOSCIENCES INC.
  • CELL THERAPIES PTY LTD.
  • CELLULAR BIOMEDICINE GROUP INC.
  • IOVANCE BIOTHERAPEUTICS INC.
  • LONZA GROUP LTD.
  • MERCK KGAA
  • NEUROGENERATION INC.
  • NOVARTIS AG
  • REGEN BIOPHARMA INC.
  • REGENEUS LTD.

第10章 附錄:參考資料

目錄
Product Code: BIO211A

Highlights:

The global market for cell therapy biomanufacturing should grow from $6.5 billion in 2020 to $10.2 billion by 2025, at compound annual growth rate (CAGR) of 9.4% for the period of 2020-2025.

The type of therapy for cell therapy biomanufacturing should grow from $3.6 billion in 2020 to $5.4 billion by 2025, at a CAGR of 8.4% for the period of 2020-2025.

The source of cells for cell therapy biomanufacturing should grow from $2.9 billion in 2020 to $4.8 billion by 2025, at a CAGR of 10.6% for the period of 2020-2025.

Report Scope:

This research report presents an in-depth analysis of the global cell therapy biomanufacturing market by product type, application and region. The report discusses the key inhibitors to the growth of cell therapy biomanufacturing. The report discusses the role of participants in the supply chain from manufacturers to researchers. The report analyzes key companies operating in the global cell therapy biomanufacturing market. In-depth patent analysis in the report will provide a look at the existing and coming technological trends.

In this report, the cell therapy biomanufacturing market is segmented by product type, application and region. Based on product type, the market is segmented into source of cells (T-cells, Dendritic cells, tumor cells and stem cells), and type of therapy (autologous cell therapies, allogeneic cell therapies). The market by application is categorized into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair, cancer and others. The market by region is segmented into North America, Europe, Asia-Pacific and ROW.

Report Includes:

  • 23 tables
  • An overview of the global markets for cell therapy biomanufacturing
  • Estimation of the market size and analyses of global market trends with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
  • Detailed description of allogeneic (third party donor cells) and autologous (one's own body cells) forms of cell therapy and analysis of its advantages and limitations
  • Information on clinical trials of cell therapies; insights into regulatory scenarios and initiatives by government organization
  • Evaluation of current market trends, market size, market forecast, and technological advancements within the industry
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies; and a relevant patent analysis
  • Company profiles of major players of the industry, including Bristol-Myers Squibb Co., Caladrius Biosciences Inc., Lonza Group Ltd., Merck KGaA and Novartis AG

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Market Estimates
  • Information Sources
  • Primary Research
  • Secondary Research
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Introduction

Chapter 3 Market and Technology Background

  • Introduction to Cell Therapy Biomanufacturing
  • What is Cell Therapy?
  • Stem Cell Transplantation
  • Autologous
  • Allogeneic
  • Syngeneic
  • Stem Cell Biomanufacturing and Classification
  • Based on Ability to Differentiate
  • Based on Source
  • Classification of Cell-Based Therapy Technology
  • Somatic Cell Technologies
  • Three-Dimensional Technologies
  • Cell Immortalization Technologies
  • Genome Editing Technologies
  • Cell Plasticity Technologies
  • Ex vivo Gene Modification of Cells Using Viral Vector Technologies
  • In vivo Gene Modification of Cells Using Viral Vector Technologies
  • Stem Cell Applications
  • Mechanism of Cell Therapy
  • Delivery Method of Cell-Based Therapy
  • Manufacturing Cell Therapy Models
  • Role of Contract Manufacturers
  • Ongoing Clinical Trials
  • Clinical Trial Network Focused on Stem Cell Treatments

Chapter 4 Market Trends and Challenges

  • Challenges
  • Drivers
  • Restraints
  • Opportunity

Chapter 5 Market Breakdown by Product Type

  • Type of Therapy
  • Source of Cells
  • Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy

Chapter 6 Market Breakdown by Application

  • Cardiovascular Disease
  • Microparticles Cell Imitation
  • Bone Repair
  • Neurological Disorders
  • Spinal Cord Injury
  • Stroke
  • Parkinson's Disease
  • Amyotrophic Lateral Sclerosis
  • Multiple Sclerosis
  • Cerebral Palsy
  • Alzheimer's Disease
  • Vision Restoration
  • Vertebral Repair
  • Batten's Disease
  • Skeletal Muscle Repair
  • Intrinsic Healing Mechanisms
  • Cell Therapy Mechanism
  • Cancer
  • Other Diseases

Chapter 7 Market Breakdown by Region

  • Market Overview
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Cardiovascular Diseases in Europe
  • Contributing Factors for Cardiovascular Diseases (CVD)
  • Germany
  • U.K.
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • Rest of APAC
  • Rest of the World
  • South America
  • Middle East and Africa

Chapter 8 Regulatory Structure

  • FDA Approvals
  • Cell Therapy for CBER Regulations
  • Federal Regulation codes
  • Collection of Cells
  • Code of Regulation
  • Legislation Governing Use of Stem Cell Treatments
  • EU Determination of Regulatory Status
  • Regulatory Scenario in India

Chapter 9 Company Profiles

  • BONE THERAPEUTICS SA
  • BRISTOL-MYERS SQUIBB CO.
  • CALADRIUS BIOSCIENCES INC.
  • CELL THERAPIES PTY LTD.
  • CELLULAR BIOMEDICINE GROUP INC.
  • IOVANCE BIOTHERAPEUTICS INC.
  • LONZA GROUP LTD.
  • MERCK KGAA
  • NEUROGENERATION INC.
  • NOVARTIS AG
  • REGEN BIOPHARMA INC.
  • REGENEUS LTD.

Chapter 10 Appendix: References

  • Sources

List of Tables

  • Summary Table : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2025
  • Table 1 : Types of Stem Cells
  • Table 2 : Global Market for Cell Therapy Biomanufacturing, by Type of Therapy, Through 2025
  • Table 3 : Global Market for Cell Therapy Biomanufacturing, by Source of Cells, Through 2025
  • Table 4 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2025
  • Table 5 : Treatments for Cardiovascular Diseases
  • Table 6 : Global Market for Cell Therapy Biomanufacturing for Cardiovascular Disease Applications, Through 2025
  • Table 7 : Global Market for Cell Therapy Biomanufacturing for Bone Repair Applications, Through 2025
  • Table 8 : Global Market for Cell Therapy Biomanufacturing for Neurological Disorder Applications, Through 2025
  • Table 9 : Global Market for Cell Therapy Biomanufacturing for Skeletal Muscle Repair Applications, Through 2025
  • Table 10 : Global Market for Cell Therapy Biomanufacturing for Cancer Treatment Applications, Through 2025
  • Table 11 : Global Market for Cell Therapy Biomanufacturing for Other Applications, Through 2025
  • Table 12 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2025
  • Table 13 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2025
  • Table 14 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2025
  • Table 15 : Stem Cell Treatment Provided in Australia
  • Table 16 : Bone Therapeutics: Products
  • Table 17 : Bristol-Myers Squibb: Net Revenue, 2017-2019
  • Table 18 : Caladrius Biosciences: Products
  • Table 19 : Iovance Biotherapeutics: Products
  • Table 20 : Merck KGaA: Products
  • Table 21 : Regen BioPharma: Products
  • Table 22 : Regeneus: Products

List of Figures

  • Summary Figure : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2019-2025
  • Figure 1 : Combination of Stem Cells and Biomaterials
  • Figure 2 : Global Market for Cell Therapy Biomanufacturing Market, by Product Type, 2019-2025
  • Figure 3 : Autologous and Allogeneic Cell Therapy Based on Source
  • Figure 4 : Mechanism of Bone Marrow
  • Figure 5 : Global Market for Cell Therapy Biomanufacturing, by Region, 2019-2025
  • Figure 6 : Global Market Share for Cell Therapy Biomanufacturing, by Region, 2025
  • Figure 7 : North American Market for Cell Therapy Biomanufacturing, 2019-2025
  • Figure 8 : North American Market Share for Cell Therapy Biomanufacturing, by Country, 2019
  • Figure 9 : European Market for Cell Therapy Biomanufacturing, 2019-2025
  • Figure 10 : European Market Share for Cell Therapy Biomanufacturing, by Country, 2019
  • Figure 11 : Asia-Pacific Market for Cell Therapy Biomanufacturing, 2019-2025
  • Figure 12 : Asia-Pacific Market Share for Cell Therapy Biomanufacturing, by Country, 2019
  • Figure 13 : South American Market for Cell Therapy Biomanufacturing, 2019-2025
  • Figure 14 : Middle Eastern and African Market for Cell Therapy Biomanufacturing, 2019-2025